The latest myeloma news
ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results
Promising pre-clinical results using a bispecific T-cell engager (BiTE), an experimental immunotherapy agent to attack…
Browsing: Myeloma
Tiny filters help detect cancerous blood cells
Multiple myeloma is a type of blood cancer in which malignant plasma cells, a type…
Protected: New triplet therapy for patients with multiple myeloma now TGA approved
This content is password protected. To view it please enter your password below: Password:
Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues…
EHA 2019: Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in relapsed / refractory multiple myleoma
Multiple myeloma is the second most common haematological cancer, and despite significant progress in the…
Renegade fat cells induce bone-damaging lesions in multiple myeloma
A study of samples from patients with multiple myeloma (MM) has demonstrated how “reprogrammed” fat…
ASCO 2019: Lenalidomide reduces risk that precancer myeloma will progress to overt multiple myeloma in high risk individuals
“Living with the uncertainty of whether cancer will develop is very difficult, so it’s exciting…
ASH 2018: Daratumumab increases progression-free survival in transplant-ineligible multiple myeloma
Interim results from a large international phase III clinical trial show that adding the immunotherapy…
ASH 2018: New research on stem cell transplantation for myeloid cancers
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation was the focus…
Looking at the urine and blood may be best in diagnosing myeloma
When it comes to diagnosing a condition in which the plasma cells that normally make…